Advertisement

Advertisement

JCCC 2026 Issue 3

Table of Contents

D’Arcy L. Little MD, CCFP, FCFP, FRCPC
In this issue of the Journal of Current Clinical Care, we present articles spanning the escalating crisis of antimicrobial resistance, a landmark advance in Alzheimer’s disease treatment, and the enduring humanity at the heart of the patient–physician relationship.
Radiology
D’Arcy L. Little MD, CCFP, FCFP, FRCPC
Lecanemab (Leqembi®), approved by Health Canada in October 2025, represents Canada’s first disease-modifying therapy for Alzheimer’s disease.
Infectious Diseases
Nsisong Asanga MBBCh, MPH, FIMC
As antibiotic development lags, AI-driven discovery, soil-derived compounds like teixobactin, and phage therapy offer renewed hope.
Medical Narratives
William J. Watson MSc, MD, CCFP, FCFP
When I checked my day schedule, I saw his name and had a deep sigh.
Marina Abdel Malak MD, CCFP, BSc.N
In this episode, Dr. Malak offers an overview of cancer screening in primary care.